STOCK TITAN
  1. Home
  2. News
  3. MMSI

Merit Medical Systems Inc - MMSI STOCK NEWS

Welcome to our dedicated page for Merit Medical Systems news (Ticker: MMSI), a resource for investors and traders seeking the latest updates and insights on Merit Medical Systems stock.

Merit Medical Systems Inc (NASDAQ: MMSI) is a leading manufacturer of medical devices used in diagnostic and interventional cardiology, radiology, and endoscopy procedures. Headquartered in South Jordan, Utah, the company employs approximately 7,000 individuals globally. Merit Medical's extensive product portfolio includes inflation devices for angioplasty and stent placement, diagnostic and therapeutic catheters, guide wires, thrombolytic catheters, fluid dispensing systems, angiography accessories, and custom angiography kits. The company's products are marketed across the United States, Europe, and around the world through direct sales forces and distributors.

Merit Medical operates primarily in two segments: Cardiovascular, which constitutes the majority of its revenue, and Endoscopy. The company is renowned for its innovative healthcare technology, with recent notable achievements including FDA 510(k) clearance for their SCOUT® MD™ Surgical Guidance System, designed to enhance the precision of tumor excision in breast cancer surgeries.

In 2024, Merit Medical commenced the MOTION study, a multicenter, prospective, randomized, controlled trial comparing genicular artery embolization (GAE) using Embosphere® Microspheres to corticosteroid injections for treating knee osteoarthritis. This study underscores the company's commitment to evidence-based medicine and patient-centric care. Additionally, the company recently launched the Micro ACE Advanced Micro-Access System and the Siege Vascular Plug, which are expected to significantly improve patient outcomes in vascular procedures.

Financially, the company has introduced a Continued Growth Initiatives Program with robust targets set for 2026. Merit Medical has consistently focused on innovation, investment in research, and strategic expansion, making it a pivotal player in the medical technology sector.

For the latest updates and detailed financial data, Merit Medical Systems regularly schedules earnings calls and provides comprehensive reports which can be accessed by interested stakeholders.

News

Merit Medical to Host Evening of Innovation during the 2024 Society of Interventional Radiology (SIR) Annual Scientific Meeting

Rhea-AI Summary
Merit Medical Systems, Inc. (NASDAQ: MMSI) will host educational events for clinicians attending the 2024 SIR Annual Meeting at their Salt Lake City headquarters and SIR booth 320. The Evening of Innovation on March 26 will feature talks by Chairman and CEO Fred Lampropoulos, a reception, facility tour, and hands-on learning opportunities.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.83%
Tags
conferences
-
News

Merit Medical Reports Results For Fourth Quarter and Year Ended December 31, 2023 - Issues Fiscal Year 2024 Guidance

Rhea-AI Summary
Merit Medical Systems, Inc. reported revenue of $324.5 million for Q4 2023, showing a 10.6% increase year-over-year. The company also achieved an 8.3% growth in constant currency revenue. Merit's GAAP operating margin was 10.4%, with a non-GAAP operating margin of 18.2%. The GAAP EPS was $0.47, while the non-GAAP EPS stood at $0.81. The company introduced financial guidance for fiscal year 2024, highlighting stable growth and profitability.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.9%
Tags
earnings
-
News

Merit Medical Introduces “Continued Growth Initiatives” Program and Financial Targets for Three-Year Period Ending December 31, 2026

Rhea-AI Summary
Merit Medical Systems, Inc. introduces Continued Growth Initiatives Program with financial targets for the three-year period ending December 31, 2026. Targets include 5-7% organic revenue growth, 20-22% non-GAAP operating margin, and $400 million cumulative free cash flow generation.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.9%
Tags
none
News

Merit Medical Receives FDA 510(k) Clearance for SCOUT® MD™ Surgical Guidance System

Rhea-AI Summary
Merit Medical Systems, Inc. (MMSI) receives FDA clearance for SCOUT MD Surgical Guidance System, a breakthrough in breast cancer care. The system targets tumor location in multiple dimensions for precise excision, reducing the need for repeat surgeries and improving patient outcomes.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.25%
Tags
clinical trial
-
News

First Patient Enrolled in Merit Medical’s MOTION Study

Rhea-AI Summary
Merit Medical Systems, Inc. announces the enrollment of the first patient in its multicenter clinical trial comparing genicular artery embolization (GAE) to corticosteroid injections for knee osteoarthritis. The MOTION study aims to evaluate the safety and effectiveness of Embosphere Microspheres for pain relief, with the potential to set a new standard in knee-pain management.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.05%
Tags
none
-
News

Merit Medical Announces Projected Preliminary Unaudited Revenue for the Year Ended December 31, 2023 and Plans to Announce Fourth Quarter and Year End 2023 Results and Issue Fiscal Year 2024 Guidance on February 28, 2024

Rhea-AI Summary
Merit Medical Systems, projected a preliminary unaudited revenue of approximately $1.255 to $1.259 billion for the year ended December 31, 2023, showing a projected increase of approximately 9.0% to 9.4% compared to the previous year. The projected preliminary unaudited constant currency revenue for the same period increased in the range of approximately 9.6% to 9.9%. The company plans to announce its financial results for the fourth quarter and year ended December 31, 2023, and issue fiscal year 2024 guidance after the close of the stock market on Wednesday, February 28, 2024. The company's ticker symbol is MMSI.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.34%
Tags
earnings
News

Merit Medical to Present at the J.P. Morgan 42nd Annual Healthcare Conference

Rhea-AI Summary
Merit Medical Systems, Inc. (NASDAQ: MMSI) Chairman and CEO Fred Lampropoulos will present at the J.P. Morgan 42nd Annual Healthcare Conference on January 8, 2024, at 4:30pm PT. The company's live audio webcast will be available on the investor section of the Merit Medical website www.merit.com. Mr. Lampropoulos expressed excitement to share the company's mission of product innovation to improve patients' lives.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.06%
Tags
conferences
-
News

Merit Medical Announces Process for Chief Executive Officer Succession Planning

Rhea-AI Summary
Merit Medical Systems, Inc. (NASDAQ: MMSI) outlines the CEO succession planning process, with Fred Lampropoulos continuing as CEO and President through December 31, 2025. A special steering committee is developing a succession plan, with Korn Ferry assisting in identifying potential candidates.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.31%
Tags
none
-
News

Merit Medical Announces Pricing of Upsized Private Offering of $650.0 Million of 3.00% Convertible Senior Notes Due 2029

Rhea-AI Summary
Merit Medical Systems, Inc. (MMSI) announced the pricing of $650.0 million aggregate principal amount of 3.00% Convertible Senior Notes due 2029 in a private placement to qualified institutional buyers. The offering was upsized from the previously announced offering of $550 million aggregate principal amount of notes. The notes will bear interest at 3.00% per year, payable semi-annually. The initial conversion rate of the notes will be 11.5171 shares of Merit’s common stock per $1,000 principal amount of notes, representing a premium of approximately 32.5% over the last reported sale price of Merit’s common stock on the Nasdaq Global Select Market on December 5, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.67%
Tags
offering
News

Merit Medical Announces Proposed Private Placement of $550 Million of Convertible Senior Notes

Rhea-AI Summary
Merit Medical Systems, Inc. (Nasdaq: MMSI) plans to offer $550.0 million aggregate principal amount of Convertible Senior Notes due 2029 in a private placement. The notes will be senior unsecured obligations, with interest payable semiannually in arrears, and will be convertible to cash, shares of Merit's common stock, or a combination of both. The company intends to use the net proceeds for general corporate purposes, including repayment of existing debt, sales and marketing activities, research and development, and potential acquisitions. Merit also plans to enter into capped call transactions to reduce potential dilution to its common stock upon conversion of notes.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-11.37%
Tags
none

FAQ

What is the current stock price of Merit Medical Systems (MMSI)?

The current stock price of Merit Medical Systems (MMSI) is $98.22 as of December 20, 2024.

What is the market cap of Merit Medical Systems (MMSI)?

The market cap of Merit Medical Systems (MMSI) is approximately 5.7B.

What does Merit Medical Systems Inc specialize in?

Merit Medical Systems Inc specializes in manufacturing medical devices for diagnostic and interventional cardiology, radiology, and endoscopy procedures.

Where is Merit Medical Systems headquartered?

Merit Medical Systems is headquartered in South Jordan, Utah, a suburb of Salt Lake City.

What are the main product segments of Merit Medical Systems?

The main product segments of Merit Medical Systems are Cardiovascular and Endoscopy, with the majority of revenue generated from the Cardiovascular segment.

What recent study has Merit Medical initiated?

Merit Medical has initiated the MOTION study, comparing genicular artery embolization using Embosphere® Microspheres to corticosteroid injections for knee osteoarthritis treatment.

What is the SCOUT® MD™ Surgical Guidance System?

The SCOUT® MD™ Surgical Guidance System is a newly FDA-cleared product designed to enhance the precision of tumor excision in breast cancer surgeries.

How does Merit Medical distribute its products?

Merit Medical distributes its products through a direct sales force in the United States and Europe and through distributors globally.

What is the significance of the Micro ACE Advanced Micro-Access System?

The Micro ACE Advanced Micro-Access System is an innovative device designed to achieve micro-access in a wide range of vascular anatomies, enhancing patient care in interventional procedures.

What is the Siege Vascular Plug used for?

The Siege Vascular Plug is used for embolization, a minimally invasive procedure to occlude blood vessels, and is designed for precise placement and rapid vessel occlusion.

What is Merit Medical's employment size?

Merit Medical employs approximately 7,000 individuals worldwide.

What are some of the financial initiatives of Merit Medical?

Merit Medical has launched a Continued Growth Initiatives Program and has set ambitious financial targets for 2026, focusing on organic revenue growth and operating margin improvements.

Stock MMSI logo
Merit Medical Systems Inc

Nasdaq:MMSI

MMSI Rankings

#1181 Ranked by Market Cap
N/A Ranked by Dividends

MMSI Stock Data

5.74B
56.84M
2.48%
104.38%
4.4%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States of America
SOUTH JORDAN